Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY: BHC )

5.480 +0.310 (+6.00%)
Official Closing Price Updated: 4:10 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism'
With so much going on in the banking space, sentiment continues to remain jittery. The index futures point to a mixed opening on Thursday, as the tech space exuded optimism ahead of Apple, Inc.’s... 
Via Benzinga
Bausch Health Announces First-Quarter 2023 Results
Via ACCESSWIRE
New Artificial Intelligence Tool Can Diagnose Colon Cancer
A new artificial intelligence (AI) model developed by Harvard Medical School and Taiwan’s National Cheng Kung University could provide much-needed clarity to clinicians presenting prognoses and... 
Via PressReach
Topics Artificial Intelligence Death
Exposures Artificial Intelligence Death Product Safety
Ortho Dermatologics Announces U.S. Food and Drug Administration New Drug Application Filing Acceptance for Investigational Acne Treatment IDP-126 Gel
Via ACCESSWIRE
Salix Partners with the Colorectal Cancer Alliance on Community Screening Program
Via ACCESSWIRE
Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate's Untapped Value
Cantor Fitzgerald has initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE) with an Overweight rating and a  
Via Benzinga
Bausch Health to Announce First-Quarter 2023 Results on May 4
Via ACCESSWIRE
New Research: More Than Half of IBS Patients Surveyed Report Waiting More Than One Year Before Discussing IBS Symptoms With Their Healthcare Provider
Via ACCESSWIRE
Bausch Health Announces Changes to its Board of Directors
Via ACCESSWIRE
Bausch Health's (BHC) Q4 Earnings & Sales Beat, Shares Up
The company’s adjusted earnings per share of $1.02, which beat the Zacks Consensus Estimate of 92 cents and our estimate of 84 cents but decreased from $1.29 reported in the year-ago quarter. 
Via Talk Markets
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Bausch Health Shares Are Trading Higher Today
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results
Via ACCESSWIRE
Preview: Bausch Health Companies's Earnings
Via Benzinga
Salix Announces 2023 Gastrointestinal Health Scholars Program
Via ACCESSWIRE
Looking Into Bausch Health Companies's Return On Capital Employed
Via Benzinga
Bausch Health Companies's Return On Capital Employed Insights
Via Benzinga
Bausch Health to Announce Fourth-Quarter and Full-Year 2022 Results on Feb. 23
Via ACCESSWIRE
'I Say, Move On': Cramer Prefers Nvidia Over This Cloud-Base Content Management Company Up 22%
On CNBC’s "Mad Money Lightning Round," Jim Cramer said L3Harris Technologies Inc (NYSE: LHX) is still a buy. 
Via Benzinga
7 Retirement Stocks to Buy Now OR You’ll Be Kicking Yourself Later
Consider adding these leading companies to a portfolio that is aimed at getting you to the finish line when it comes to retiring. 
Via InvestorPlace
Most Active Equity Options For Midday - Monday, Jan. 23
Here are the most active equity options for midday. 
Via Talk Markets
Battered FTX's CEO Sam Bankman-Fried Arrested, Elon Musk's SpaceX Mammoth Valuation Of $140B, China Weighs Over $143B In Semiconductor Push: Top Stories Tuesday, Dec. 13
Benzinga Sam Bankman-Fried Arrested In The Bahamas 
Via Benzinga
Bausch Health Investors Request Blocking Eye-Care Business Spinoff, Alleging Protection From Lawsuits
More than 50 funds that own Bausch Health Companies Inc (NYSE: BHC) investors are reportedly seeking to block the eye-care business spin-off, Bausch + Lomb Corp (NYSE: BLCO). 
Via Benzinga
Bausch Health Wins DUOBRII(R) and BRYHALI(R) Patent Infringement Case
Via ACCESSWIRE
PVH, Five Below, Okta And Some Other Big Stocks Moving Higher On Thursday
U.S. stocks traded mostly lower, with the Dow Jones dropping over 300 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Why Dollar General Shares Are Trading Lower By Over 8%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session
Gainers Top Ships Inc. (NASDAQ: TOPS) shares jumped 74% to $5.24. Vapotherm, Inc. (NASDAQ: VAPO) gained 48.8% to $1.3250. 
Via Benzinga
Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider
Via ACCESSWIRE
Struggling Axsome Stock Could Bounce Back on Drug Trial Success
Axsome Pharmaceuticals may be struggling to get out of the red but the success of two very recent drug trials could quickly change all of that. 
Via MarketBeat
Exposures Product Safety
Bausch Health Announces the Unrestricting of Bausch + Lomb Under Bausch Health Debt Documents
Via ACCESSWIRE
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.